Dr. Prashant Nahar, Ph.D.

Dr. Nahar brings over twelve years of extensive experience in drug discovery, and in the preclinical and clinical development of new chemical entities. His expertise also spans the development of generic drugs across a wide range of technology-driven immediate-release dosage forms and novel drug delivery systems, as well as the development of non-infringing, commercially viable, and complex technologies for active pharmaceutical ingredients. He has a strong understanding of emerging API technologies, including asymmetric synthesis, biocatalysts, reaction calorimetry, and peptides, along with deep familiarity with global regulatory affairs, intellectual property, clinical pharmacology and pharmacokinetics, and compliance and quality requirements.

Dr. Nahar holds a Ph.D. in Synthetic Organic Chemistry from NPL and is a Fellow at CSIR. A prominent speaker at national and international scientific forums, he also represents the Company at academic and research institutions, and has authored twelve publications in leading journals.